A Pennsylvania bank holding company offering banking, wealth management, and insurance across Southeastern Pennsylvania through its Univest Bank and Trust Co. subsidiary. It also operates Girard-branded wealth services, Univest Insurance, and an equipment financing arm, serving individuals, businesses, municipalities, and nonprofits. True to its community-banking roots, it competes on local decision-making and personal service rather than size, with nearly all of its financial centers in the Philadelphia region.
Net interest margin expanded to 3.49%, but a $5.2M OREO write-down and a $28.6M commercial loan on nonaccrual status weighed on results.
A single commercial relationship drove a sharp rise in nonperforming loans. rose 14.9% to $23.0 million as the expanded to 3.49%, but noninterest income fell 15.8% on a $5.2 million . The credit story has shifted from recovery to watchfulness.
Key takeaways
A $28.6 million commercial relationship was placed on nonaccrual status, pushing total nonaccrual loans to $43.9 million from $13.7 million at year-end and compressing the to 205% from 642%.
Tax-equivalent rose 11.3% to $66.7 million as the expanded to 3.49% from 3.20% a year ago, helped by higher average earning assets and a lower cost of funds.
Noninterest income fell 15.8% to $18.1 million, driven by a $5.2 million valuation adjustment on an other real estate owned () property, which more than offset gains in investment advisory fees and mortgage banking.
Section summaries
Management's Discussion and Analysis
Q2 net income rose 14.9% to $23.0M on higher net interest income and lower deposit costs, partly offset by a $5.2M OREO write-down.
⌄
Tax-equivalent grew 11.3% to $66.7M, driven by higher average earning assets and a lower cost of funds; expanded to 3.49% from 3.20%.
Noninterest expense increased 5.5% to $53.1 million, reflecting higher salaries and benefits from annual merit increases and medical claims, plus a near-doubling of marketing and advertising spend.
Wealth Management pre-tax income rose 33% to $2.4 million on higher , and Insurance pre-tax income increased 14% to $1.1 million on growth in life and health overrides.
Total deposits decreased 2.2% to $6.93 billion, while declined $75 million due to maturing ; the Bank remains well-capitalized with a Tier 1 Common ratio of 10.76%.
What changed
The $23.7 million commercial loan relationship flagged for suspected fraud in Q2 2025 has been resolved: the remaining $16.4 million was not mentioned, but a new $28.6 million commercial relationship was placed on nonaccrual this quarter, shifting the credit concern to a different borrower.
The continued to expand, reaching 3.49% from 3.33% in Q1 2026 and 3.20% a year ago, sustaining the trajectory of improvement as funding costs declined.
Nonperforming assets, which rose to $41.2 million in Q1 2026 on an increase in accruing loans 90+ days past due, climbed further as the $28.6 million nonaccrual addition drove nonaccrual loans to $43.9 million.
The Wealth Management and Insurance segments sustained their pre-tax income growth, with Wealth Management pre-tax income rising 33% , continuing the trend of fee-based businesses offsetting pressure.
What to watch
Whether the $28.6 million commercial relationship placed on nonaccrual this quarter results in charge-offs, and the effect on the and the .
Whether the continues to expand beyond 3.49% as the Federal Reserve holds or lowers rates, and whether the liability-sensitive position sustains growth.
Whether the $5.2 million is a one-time event or signals broader deterioration in the commercial real estate portfolio.
Whether total deposits stabilize after the 2.2% decline, and whether the funding mix shifts further toward higher-cost deposits.
Noninterest income fell 15.8% to $18.1M, primarily due to a $5.2M valuation adjustment on an property, partially offset by gains in investment advisory fees and mortgage banking.
Noninterest expense increased 5.5% to $53.1M, reflecting higher salaries and benefits from annual merit increases and medical claims, plus a near-doubling of marketing and advertising spend.
Credit quality weakened as surged to $43.9M from $13.7M at year-end, driven by a $28.6M commercial relationship placed on nonaccrual; the allowance coverage ratio fell to 205% from 642%.
Total deposits decreased 2.2% to $6.93B, while declined $75M due to maturing FHLB advances; the Bank remains well-capitalized with a Tier 1 Common ratio of 10.76%.
Wealth Management pre-tax income rose 33% to $2.4M on higher , and Insurance pre-tax income increased 14% to $1.1M on growth in life and health overrides.
Quantitative and Qualitative Disclosures About Market Risk
No material changes in the Corporation’s market risk occurred during the period ended June 30, 2026. A detailed discussion of market risk is provided in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" including Liquidity and Intere…
⌄
No material changes in the Corporation’s market risk occurred during the period ended June 30, 2026. A detailed discussion of market risk is provided in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" including Liquidity and Interest Sensitivity, in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2025.
The Corporation is periodically subject to various pending and threatened legal actions that involve claims for monetary relief. Based upon information presently available, it is the Corporation's opinion that any legal and financial responsibility arising from such claims will…
⌄
The Corporation is periodically subject to various pending and threatened legal actions that involve claims for monetary relief. Based upon information presently available, it is the Corporation's opinion that any legal and financial responsibility arising from such claims will not have a material adverse effect on the Corporation's results of operations, financial position or cash flows.
There have been no material changes in risk factors applicable to the Corporation from those disclosed in "Risk Factors" in Item 1A of the Corporation's Annual Report on Form 10-K for the year ended December 31, 2025. 65 Table of Contents
⌄
There have been no material changes in risk factors applicable to the Corporation from those disclosed in "Risk Factors" in Item 1A of the Corporation's Annual Report on Form 10-K for the year ended December 31, 2025.
65
Table of Contents